Diagnostics

Latest News

US Cost-effectiveness and Budget Impact of Point-of-Care NAAT for Streptococcus

By S. Pinar Bilir, MS
Eliza Kruger, MHEcon

May 12th 2021

This study evaluates the cost-effectiveness and budget impact to US payers of point-of-care nucleic acid amplification tests (NAAT) for group A streptococcus.

Putting the Patient Back at the Center of Patient-Centered Care

By Joseph Alvarnas, MD

April 11th 2020

Personalized Medicine: The Role of Technology and Diagnostics in Driving Change

By Laura Joszt, MA
Mary Caffrey

March 3rd 2020

Study Finds Imaging Technique Could Replace Riskier Diagnostic Method for Diabetic Retinopathy

Study Finds Imaging Technique Could Replace Riskier Diagnostic Method for Diabetic Retinopathy

By Mary Caffrey

August 30th 2019

Cancer & Blood Specialists of Louisville Adds New PET/CT Scanner to Improve Cancer Treatment

August 26th 2019

More News

September 13th 2018

“Precision Health” for High-Need, High-Cost Patients

Dhruv Khullar, MD, MPP Rainu Kaushal, MD, MPH

Better care for high-need, high-cost patients will require targeted care delivery models based on integrated data networks that include clinical, genomic, and social information. Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.

August 24th 2018

A Model for Delivering Population Health Across the Care Continuum

Sanjula Jain, PhD Adam S. Wilk, PhD Kenneth E. Thorpe, PhD S. Patrick Hammond, MHA

The Population Health Care Delivery Model presents delivery systems with a framework for developing, piloting, and implementing population health programs across the continuum of care.

December 1st 2017

Bridging the Gap: Patient Expectations, Changing Technology and the Prepared Health Workforce

The gap between patients and technology can be overcome with workforce ready to handle innovation and communicate value to patients.

August 17th 2017

The Hospital Tech Laboratory: Quality Innovation in a New Era of Value-Conscious Care

Courtland K. Keteyian, MD, MBA, MPH Brahmajee K. Nallamothu, MD, MPH Andrew M. Ryan, PhD

Technology innovation drives expenditures. A Michigan Medicine, IBM, and AirStrip partnership demonstrates the hospital’s role in developing transformative technologies that deliver value.

August 4th 2016

Myriad to Acquire Assurex, Maker of Test That Directs Treatment in Depression

The GeneSight test address an unmet need that mental health leaders have wanted for years: a way to avoid the "try until it fails" approach in selecting anti-depressants.

August 31st 2015

How "Clinical Efficacy" Can Rein in Healthcare Costs

The latest installment in the 20th anniversary commentary series in The American Journal of Managed Care explores the concept of "clinical efficacy." This healthcare delivery model asks stakeholders to make use of data and value-based contracts that reward early intervention in high-risk patients.

August 3rd 2015

Misdiagnosis of Alzheimer's Disease Is Costly for Patients

Laura Joszt, MA

The diagnosis and management of patients with dementing illnesses can be challenging, but the cost of misdiagnosing dementia as Alzheimer's disease can be as high as $14,000 a year, according to a study published in Alzheimer's & Dementia.

Segment 6: Learning About CancerLinQ as It Rolls Out

January 28th 2015

Segment 6: Learning About CancerLinQ as It Rolls Out

Daniel Hayes, MD, explains the implementation of the American Society of Clinical Oncology's CancerLinQ for beta testing.

January 26th 2015

Budget to Offer Details of Personalized Medicine Initiative, While CMS Moves to Pay for Key Tests

Mary K. Caffrey

As the personalized medicine initiative takes shape, word comes that CMS will pay for key genetic tests in lung cancer. This policy shift is a sea change after a long period of frustration for test makers in seeking reimbursement.

January 23rd 2015

Cleveland Clinic Accused of Medicare Fraud in Lawsuit

A federal lawsuit accuses the Cleveland Clinic Health System of performing more tests and procedures on patients than necessary in order to obtain more Medicare payouts.

January 23rd 2015

Early Detection, Cutting Edge Treatments for Breast Cancer Patients

In 2 interviews with Physicians' Education Resource, LLC, award-winning journalist Joan Lunden and Patrick I. Borgen, MD, of Maimonides Medical Center in Brooklyn, NY, discuss breast cancer in advance of the 32nd Annual Miami Breast Cancer Conference.

January 20th 2015

More Collaboration Among Clinicians May Reduce Medical Errors

Laura Joszt, MA

Working collaboratively leads to more accurate diagnoses and may help reduce medical errors, according to a study published in JAMA.

January 14th 2015

Diagnostic Testing Guidelines for Lung Cancer to Be Revised

In addition to recommendations on alternate techniques, the revised guideline, being jointly developed by CAP, IASLC, and AMP, will also include testing for emerging biomarkers in lung cancer.

January 9th 2015

ASCO Backs the FDA on Regulating Lab-Based Diagnostics

In comments to the House Committee on Energy and Commerce, Health Subcommittee, ASCO strongly supported the FDA's resolution to rigorously regulate laboratory-developed tests.

December 8th 2014

Bigger Regulatory Challenges in Diagnostics Than in Therapeutics, Industry Expert Says

Mary K. Caffrey

Representatives from industry and the FDA share perspectives on the state of regulation for therapeutics and diagnostics at the 56th annual meeting of the American Society of Hematology, being held in San Francisco.

December 5th 2014

Nova StatStrip Glucose Hospital Meter System Approved for Use in Critical Care Patients

November 17th 2014

Fertility Preservation in Young Cancer Patients

Surabhi Dangi-Garimella, PhD

October 29th 2014

UnitedHealth Continues Its Acquisition Spree

Optum, UHC's technology and services subsidiary, has bought Allere's wellness subsidiaries.

October 28th 2014

From Diagnostics to Cancer Drug Costs, Nothing's Off Limits at AJMCLive's Patient-Centered Oncology Care

The toughest topics in cancer care will be on tap November 13-14, 2014, in Baltimore, Maryland, when AJMCLive presents Patient-Centered Oncology Care. If you've followed the discussion among pharmaceutical leaders, oncologists, and payers over access to care, you'll want to join stakeholders to discuss how to ensure patients get what they need while controlling costs.

September 17th 2014

New Thinking on Clinical Utility: Hard Lessons for Molecular Diagnostics

John W. Peabody, MD, PhD, DTM&H, FACP Riti Shimkhada, PhD Kuo B. Tong, MS Matthew B. Zubiller, MBA

The authors describe 5 basic requirements for planning, implementing, and proving clinical utility for diagnostic tests, drawing on recent reimbursement decisions.

July 21st 2014

Value-Engineered Translation: Developing Biotherapeutics That Align With Health-System Needs

Tania Bubela, PhD, JD Christopher McCabe, PhD

March 14th 2014

Major Health Insurance Plans Say They'll Be Ready for ICD-10

For many months now, the AAFP has urged family physicians to prepare for this year's Oct. 1 deadline for implementation of the ICD-10-CM code sets for outpatient diagnostic coding.

March 10th 2014

Electronic Health Records: A Hard Pill to Swallow for Some Doctors

Electronic health records are supposed to represent the next great leap in medicine - reducing medical errors and enhancing the physician's diagnostic powers.

Bruce Feinberg, DO, Discusses Cost Effective Cancer Treatment

August 22nd 2013

Bruce Feinberg, DO, Discusses Cost Effective Cancer Treatment

Bruce Feinberg, DO, Vice President and Chief Medical Officer, Cardinal Health Specialty Solutions, says cancer treatment is more than clinical guidelines, protocols, or individual drugs.

Episode 12 - Recognizing the Strengths and Weaknesses of Current Clinical Practice Guidelines

July 23rd 2013

Episode 12 - Recognizing the Strengths and Weaknesses of Current Clinical Practice Guidelines

Episode 11 - Minimizing the Burden of SLE

July 23rd 2013

Episode 11 - Minimizing the Burden of SLE

Episode 10 - Treating Mild and Severe Hemophilia

July 23rd 2013

Episode 10 - Treating Mild and Severe Hemophilia

Episode 9 - The Future Landscape for the Treatment of Hemophilia

July 23rd 2013

Episode 9 - The Future Landscape for the Treatment of Hemophilia

Episode 8 - Long-Acting Agents and Considerations

July 23rd 2013

Episode 8 - Long-Acting Agents and Considerations

Episode 7 - Minimizing the Burden of SLE

July 23rd 2013

Episode 7 - Minimizing the Burden of SLE

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions